Patent · US Active

Anti-hOX40L antibodies, uses, and methods

US9587030B2 · kind B2 · utility

8Cited by
13References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 8, 2016
Grant dateMar 7, 2017
Priority date
Expiry dateSep 8, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to anti-human OX40L antibodies, new medical uses and methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.